title: Activation of the medial prefrontal and posterior cingulate cortex during encoding of negative material predicts symptom worsening in major depression.
abstract: Considerable research indicates that depressed individuals have better memory for negative material than do nondepressed individuals, and that this bias is associated with differential patterns of neural activation. It is not known, however, whether these aberrant activation patterns predict illness course. Using functional neuroimaging, we examined whether change in depressive symptoms is predicted by baseline patterns of neural activation that underlie negative memory biases in major depressive disorder. Depressed participants viewed negative and neutral pictures during functional MRI at baseline and completed an incidental memory task for these pictures 1 week later. Depression severity was assessed by administering the Beck Depression Inventory both at baseline (Time 1) and at Time 2, an average of 18 months later. Contrast maps of activation for subsequently remembered negative versus subsequently remembered neutral pictures were regressed against change in Beck Depression Inventory scores between Time 1 and Time 2, controlling for initial symptom severity. Results from this analysis revealed no associations between memory sensitivity for negative stimuli and symptom change. In contrast, whole brain analyses revealed significant positive associations between within-subject changes in depressive symptoms and baseline neural activation to successfully recalled negative pictures in the posterior cingulate cortex and medial prefrontal cortex. These findings indicate that neural activation in cortical midline regions is a better predictor of long-term symptomatic outcome than is memory sensitivity for negative material.
authors.affiliation: aDepartment of Psychology, Stanford University bNeurosciences Program, Stanford University School of Medicine, Stanford, California cLaureate Institute for Brain Research, Tulsa, Oklahoma, USA.
authors.forename: Lara C
authors.initials: LC
authors.lastname: Foland-Ross
authors.forename: Paul
authors.initials: P
authors.lastname: Hamilton
authors.forename: Matthew D
authors.initials: MD
authors.lastname: Sacchet
authors.forename: Daniella J
authors.initials: DJ
authors.lastname: Furman
authors.forename: Lindsey
authors.initials: L
authors.lastname: Sherdell
authors.forename: Ian H
authors.initials: IH
authors.lastname: Gotlib
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D003865:Major Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology*; D004644:Emotions / Q000502:physiology*; D005260:Female; D005500:Follow-Up Studies; D006179:Gyrus Cinguli / Q000503:physiopathology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008568:Memory / Q000502:physiology*; D010775:Photic Stimulation; D017397:Prefrontal Cortex / Q000503:physiopathology*; D011379:Prognosis; D011569:Psychiatric Status Rating Scales; D021641:Recognition, Psychology / Q000502:physiology; D013997:Time Factors; D014796:Visual Perception / Q000502:physiology
chemical_list: D000928:Antidepressive Agents